Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04849273 |
| Title | A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Turning Point Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Local Institution - 2104 | Orange | California | 92868 | United States | Details | |
| Local Institution - 2105 | Aurora | Colorado | 80045 | United States | Details | |
| Local Institution - 2106 | Boston | Massachusetts | 02114-2696 | United States | Details | |
| Local Institution - 2108 | Boston | Massachusetts | 02215 | United States | Details | |
| Local Institution - 2103 | Hackensack | New Jersey | 07601 | United States | Details | |
| Local Institution - 2107 | Nashville | Tennessee | 37203 | United States | Details | |
| Local Institution - 2102 | Fairfax | Virginia | 22031-4629 | United States | Details | |
| Local Institution - 6102 | Blacktown | New South Wales | 2148 | Australia | Details | |
| Local Institution - 6103 | Heidelberg | Victoria | 3084 | Australia | Details | |
| Local Institution - 6104 | Melbourne | Victoria | 3000 | Australia | Details | |
| Local Institution - 6101 | Nedlands | Western Australia | 6009 | Australia | Details | |
| Local Institution - 6303 | Seoul | Seoul-teukbyeolsi | 05505 | South Korea | Details | |
| Local Institution - 6301 | Seoul | 03722 | South Korea | Details | ||
| Local Institution - 6302 | Seoul | 06351 | South Korea | Details | ||
| Local Institution - 6304 | Seoul | 110-744 | South Korea | Details |